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Abstract
In mammalian species, mitochondrial DNA (mtDNA) with pathogenic mutations that induce mitochondrial respiration
defects has been proposed to be involved in tumor phenotypes via induction of enhanced glycolysis under normoxic
conditions (the Warburg effects). However, because both nuclear DNA and mtDNA control mitochondrial respiratory
function, it is difficult to exclude the possible contribution of nuclear DNA mutations to mitochondrial respiration
defects and the resultant expression of tumor phenotypes. Therefore, it is important to generate transmitochondrial
cybrids sharing the same nuclear DNA background but carrying mtDNA with and without the mutations by using
intercellular mtDNA transfer technology. Our previous studies isolated transmitochondrial cybrids and showed that
specific mtDNA mutations enhanced tumor progression as a consequence of overproduction of reactive oxygen
species (ROS). This study assessed whether mtDNA mutations inducing ROS overproduction always enhance tumor
progression. We introduced mtDNA from senescence-accelerated mice P1 (SAMP1) into C57BL/6J (B6) mice-
derived Lewis lung carcinoma P29 cells, and isolated new transmitochondrial cybrids (P29mtSAMP1 cybrids) that
overproduced ROS. The inoculation of the cybrids into B6 mice unexpectedly showed that mtDNA from SAMP1 mice
conversely induced tumor suppression. Moreover, the tumor suppression of P29mtSAMP1 cybrids in B6 mice
occurred as a consequence of innate immune responses of the host B6 mice. Enzyme pretreatment experiments of
P29mtSAMP1 cybrids revealed that some peptides encoded by mtDNA and expressed on the cell surface of
P29mtSAMP1 cybrids induce increased IL-6 production from innate immune cells (dendritic cells) of B6 mice, and
mediate augmented inflammatory responses around the tumor-inoculated environment. These observations indicate
presence of a novel role of mtDNA in tumor phenotype, and provide new insights into the fields of mitochondrial
tumor biology and tumor immunology.
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Introduction
Mammalian mitochondrial DNA (mtDNA) with pathogenic
mutations that induce significant mitochondrial respiration
defects causes mitochondrial diseases [1,2]. Moreover, it has
been hypothesized that pathogenic mutations in mtDNA may
also contribute to aging and age-associated disorders via
overproduction of reactive oxygen species (ROS) [1–4]. This
hypothesis, the so-called mitochondrial theory of aging, is
partly supported by studies in mtDNA mutator mice, which
possess a nuclear-encoded mtDNA polymerase with a
defective proofreading function, resulting in enhanced
expression of respiration defects with age and the subsequent
expression of premature aging phenotypes [5–7]. Furthermore,
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the accumulation of pathogenic mtDNA mutations with age and
the resultant mitochondrial respiration defects also have been
proposed to be involved in the tumor development, given that
these defects induce enhanced glycolysis under normoxic
conditions (i.e., the Warburg effect), thus providing a survival
advantage for tumor cells even under hypoxic conditions [1–4].
However, there is as yet no convincing evidence for the
contribution of mtDNA mutations to aging and tumor
phenotypes because of the dual control of mitochondrial
respiratory function by both nuclear DNA and mtDNA [1,2] and
the resultant difficulty of excluding the possible involvement of
nuclear DNA mutations in the expression of these phenotypes.
Therefore, to examine the contribution of mtDNA mutations to
aging or tumor phenotypes, it is very important to use
intercellular mtDNA transfer technology to generate
transmitochondrial cybrids or transmitochondrial mito-mice that
share the same nuclear DNA background but carry mtDNA with
and without the mutations. In our previous studies, we
generated such transmitochondrial cybrids [8,9] and
transmitochondrial mito-mice [10,11] and showed that specific
mtDNA mutations regulated tumor progression as a
consequence of their induction of ROS overproduction while
they did not regulate aging phenotypes [11].
The current study addressed the issue of whether mtDNA
mutations inducing ROS overproduction always enhance tumor
progression. For this, we isolated new transmitochondrial
P29mtSAMP1 cybrids that carry mtDNA from senescence-
accelerated mice P1 (SAMP1) [12,13] and express ROS
overproduction, and examined their tumor phenotypes. The
results were unexpected, since tumor phenotypes of Lewis
lung carcinoma P29 cells derived from C57BL/6J (B6) strain
mice were suppressed by the introduction of mtDNA from
SAMP1 mice. These observations suggest that some of
mtDNA mutations can function as suppressors of tumor
phenotypes rather than enhancers.
Materials and Methods
Cell lines and cell culture
The P29 cells, originated from B6 mouse–derived Lewis lung
carcinoma cells, were established in our previous study [14].
The mtDNA-less P29 cells (ρ0 P29 cells), and the
transmitochondrial cybrids were grown in DMEM (Sigma, St.
Louis, MO, USA) containing 10% fetal calf serum (Sanko
Junyaku, Tokyo, Japan), 50 mg/ml uridine (Sigma, St. Louis,
MO, USA), and 0.1 mg/ml sodium pyruvate (Wako Pure
Chemical Industries, Osaka, Japan).
Isolation of transmitochondrial cybrids
We used ρ0 P29 cells as nuclear donors and mtDNA
recipients for isolation of the transmitochondrial cybrids
(P29mtSAMP1 cybrids). As mtDNA donors, we used platelets
from SAMP1 mice. Platelet-containing supernatants were
prepared by low-speed centrifugation (70 × g for 15 min) of
blood obtained from SAMP1 mice. Platelets were fused with ρ0
P29 cells by polyethylene glycol. Selective isolation of
P29mtSAMP1 cybrids was attained in the selection medium
without uridine and sodium pyruvate (UP-), so that unfused
nuclear donor ρ0 P29 cells could be excluded by the selection.
Mice
Mice of the inbred strain B6 were obtained from CLEA
(Tokyo, Japan). The immunodeﬁcient B6 Rag2-/- mice were
obtained from Taconic (Hudson, NY, USA). The knockout mice
of B6 Myd88/Trif, TLR-3, TLR-7, and TLR-9 were obtained
from Bioindustry Division of Oriental Yeast (Tokyo, Japan). B6
CD11c-DTR mice, which loose CD11c+ dendritic cells (DCs) by
administration of diphtheria toxin (DTx) due to expression of its
receptor (DTR) exclusively in CD11c+ DCs [15], were obtained
from Dr. S. Koyasu (Keio University) with permission of Dr. D.
R. Littman (New York Univ. Sch. Med.). To obtain B6 NKRed
mice, B6 mice received continuous intraperitoneal injection of
anti-NK1.1 antibody (BioLegend, San Diego, CA, USA) from 1
week after the birth (10 µg/week for 1-week–old mice, 20 µg/
week for 2-week–old mice, 50 µg/week for 3- and 4-week–old
mice, and 100 µg/week for >5-week-old mice). All the
immunodeﬁcient mice used here share a B6 nuclear DNA
background. SAMP1 males were obtained from Japan SLC
(Shizuoka, Japan). Animal experiments were performed in
accordance with protocols approved by the Experimental
Animal Committee of the University of Tsukuba, Japan
(Approval number: 12070), and Institutional Animal Care and
Use Committee of the Research Institute National Center for
Global Health and Medicine (Approval number: 12023).
Genotyping of mtDNAs in the cybrids
To confirm transfer of mtDNAs from SAMP1 mice into
P29mtSAMP1 cybrids, restriction enzyme digestion of the PCR
products was carried out. For recognition of an A11181G
mutation in the ND4 gene of SAMP1 mice (Table 1), a 194-bp
fragment containing the 11181 site was amplified by PCR. The
sequences from nucleotide position 11,102 to 11,125 (AAC
AAT ACT AAT AAT CGC ACA TGG) and nucleotide position
11,295 to 11,272 (CTA TTA GAT TGA TTG AAG GGG GTA)
were used as oligonucleotide primers. Combination of the
PCR-generated mutation with the A11181G mutation creates a
restriction site for EagI, and generates 115-bp and 79-bp
fragments on EagI digestion. The restriction fragments were
separated in 3% agarose gel.
Estimation of the ROS levels
ROS generation was detected with 2′-,7′-dichlorofluorescein
diacetate (DCFH-DA) (Invitrogen, Carlsbad, CA, USA). Cells
were incubated with 5 µM DCFH-DA for 10 min at 37°C in
serum-free DMEM, washed twice with Dulbecco’s phosphate-
buffered saline (DPBS), and then immediately analyzed with a
FACScan flow cytometer (Becton Dickinson, Mountain View,
CA, USA).
Assays of tumor phenotypes
For testing tumor formation phenotype and metastatic
potential, 5 × 106 cells in 100 µl PBS were injected
subcutaneously into the back of 6-week–old male B6 mice.
Tumor growth was monitored assuming spherical growth of
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tumors. When a tumor mass was visually detectable, its
maximum (a) and minimum (b) diameters and height (h) were
recorded twice per week. The volume of each tumor (V) was
calculated according to the following formula: V =πabh/6. The
recipient mice were sacrificed by cervical dislocation when the
tumor volume reached 500 mm3.
Cytotoxic assay
51Cr-release assay was performed to examine cytotoxic
activity of cells. For preparation of poly (I:C)-activated natural
killer (NK) cells, 100 µg of poly (I:C) (Sigma, St. Louis, MO,
USA) was intraperitoneally injected to B6 Rag2-/- mice, and
spleen cells were isolated as effector cells 18 h after the
injection. The target cells (P29mtB6 and P29mtSAMP1 cybrids)
were labelled with 51Cr (3700 KBq/106 cells) for 30 min at 37°C
and used as target cells in the killer assay. After removing the
excess 51Cr by washing cells with the medium, the target cells
were plated in V-bottom 96-well plates at 104 cells/well and
mixed with effector cells in a final volume of 200 µl, and the
cytotoxic assay was performed. Spontaneous release values
were obtained from target cells in medium alone, whereas total
release values were obtained from target cells lysed in 1%
Nonidet P-40 in distilled water. The percentage of specific lysis
was calculated as follows: % of killing = [(the mean cpm
released in the presence of effector cells - spontaneous
release cpm)/(total release cpm - spontaneous release cpm)] ×
100. Spontaneous release values of target cells were less than
20% of total release values in all experiments.
Estimation of the cytokines produced by DCs
Bone marrow (BM) cells were isolated by flushing femurs
and tibiae of euthanized mice with RPMI 1640 medium
supplemented with 5% heat-inactivated FCS. The BM cells
were treated with a Tris-ammonium chloride buffer to lyse red
blood cells and plated at a concentration of 106 cells/ml into a
six-well culture dish in culture medium consisting of RPMI 1640
medium supplemented with 10% FCS, 10 mM HEPES, 2 mM l-
glutamine, 1 mM sodium pyruvate, 50 µM 2-mercaptoethanol,
1% (v/v) nonessential amino acids, 100 U/ml penicillin, 100
µg/ml streptomycin, and 100 ng/ml murine Flt3L. Every 4 days
Table 1. Comparison of sequences of mtDNA from
transmitochondrial cybrids.
Gene Position B6 P29mtSAMP1P29mtC3H
Amino acid
change
16S rRNA 2256 T C – –
ND2 4794 C – T T294I
COX3 9348 G – A V248I
ND3 9461 T C C Silent
ND4 11181 A G – T337A
ND5 12048 T – C F103L
 12395 C A – I218M
 13052 T C – Silent
GenBank accession no. AY172335 AP013054 AP013031  
doi: 10.1371/journal.pone.0075981.t001
of culture, half of the medium was removed and fresh cytokine-
supplemented culture medium was added back into the
cultures. After 8 days, DCs were harvested, plated into 96-well
plates mixed with P29mtB6 or P29mtSAMP1 cybrids. After 48
h incubation, the supernatant was harvested to measure
cytokine production by DCs by using an ELISA kit (BioLegend,
San Diego, CA, USA) and Mouse Inflammation CBA Kit
(Becton Dickinson, Mountain View, CA, USA).
Statistical analysis
All analyses and experiments were conducted at least three
times. Differences between groups of values were assessed by
using a 2-tailed unpaired Student’s t-test. All values are means
±S.D. P values < 0.05 were considered to be statistically
significant.
Results
Isolation and characterization of transmitochondrial
P29mtSAMP1 cybrids
According to the mitochondrial theory of aging [1–4],
accumulation of mtDNA mutations with age and the resultant
overexpression of ROS are responsible for aging phenotypes.
Given that SAMP1 mice express accelerated aging phenotypes
[12,13], their mtDNA can be expected to induce ROS
overproduction. Therefore, we transferred mtDNA from SAMP1
mice into mtDNA-less Lewis lung carcinoma P29 cells (ρ0 P29
cells) derived from B6 strain mice, and isolated
transmitochondrial P29mtSAMP1 cybrids carrying mtDNA from
SAMP1 mice (Table S1). Transfer of mtDNA from SAMP1 mice
into P29mtSAMP1 cybrids was confirmed by restriction enzyme
digestion of PCR products amplified by using mismatched
primers (Figure 1A). As control cybrids, we used P29mtB6
cybrids with mtDNA from B6 strain mice, which we isolated in
our previous study and which formed primary tumors in
syngenic B6 mice after subcutaneous inoculation [16]. Thus,
both P29mtB6 and P29mtSAMP1 cybrids share the nuclear
DNA from B6 mice but carry mtDNA from B6 mice and from
SAMP1 mice, respectively.
Because P29mtSAMP1 cybrids demonstrated ROS
overproduction (Figure 1B), we then examined whether mtDNA
mutations that induce ROS overproduction always enhance
tumor progression (metastasis), as we proposed in our
previous study [8]. For examination of spontaneous metastasis,
we inoculated 5 × 106 cybrids subcutaneously into B6 mice.
However, we obtained the unexpected results that
P29mtSAMP1 cybrids did not form primary tumor masses even
after 100 days, whereas P29mtB6 cybrids with mtDNA from B6
mice formed tumor masses within 10 days after inoculation
(Figure 1C). Therefore, mutations in mtDNA from SAMP1 mice
might be responsible for the suppression of the tumor formation
phenotype of Lewis lung carcinoma P29 cells. Taken together
with our previous observation [9], these results suggest that
some mtDNA mutations function as tumor suppressors (Figure
1C), while the other mtDNA mutations function as tumor
enhancers [9], even though they both induce ROS
overproduction.
Suppression of Tumorigenicity by mtDNA Mutations
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Figure 1.  Characterization of transmitochondrial
P29mtSAMP1 cybrids.  (A) Genotyping of mtDNA in
P29mtSAMP1 cybrids. As control cybrids, we used P29mtB6
cybrids with mtDNA from B6 mice [16]. To identify the
A11181G mutation in the mtDNA of P29mtSAMP1 cybrids
(Table 1), the PCR products were digested with the restriction
enzyme EagI. mtDNA with the A11181G mutation from SAMP1
mice in P29mtSAMP1 cybrids produced 115-bp and 79-bp
fragments due to the gain of an EagI site through an A to G
substitution at the nucleotide position 11181, whereas B6
mtDNA without the mutation in P29mtB6 cybrids produced a
194-bp fragment. (B) Effects of mtDNA transfer from SAMP1
mice on the ROS levels of P29mtSAMP1 cybrids. P29mtB6
and P29mtSAMP1 cybrids (1 × 106 cells) treated with 5 µM
DCFH-DA underwent flow cytometric analysis for quantitative
estimation of ROS (H2O2). (C) Tumor phenotypes of
P29mtSAMP1 cybrids. For examination of tumor phenotypes
(tumorigenicity and spontaneous metastasis), 5 × 106 cybrids
were inoculated subcutaneously into B6 mice. P29mtSAMP1
cybrids did not form primary tumor masses, whereas P29mtB6
cybrids expressed tumorigenicity by forming primary tumor
masses within 10 days after inoculation. Neither types of
cybrids formed lung nodules, suggesting that neither had a
high potential for metastasis. **P < 0.01.
doi: 10.1371/journal.pone.0075981.g001
Involvement of the immune system in the suppression
of P29mtSAMP1 tumor formation
The above result that tumor forming ability of P29 Lewis lung
carcinoma was suppressed by introducing SAMP1 mtDNA
mutations into P29 cells implied a crucial role of mtDNA
mutations in tumor suppression. We previously found that
transmitochondrial cybrids with nuclear DNA from P29 cells
and mtDNA from NZB strain mice (P29mtNZB cybrids) did not
form tumor masses in B6 mice due to the recognition and
elimination of these cybrids by the innate immune system of B6
mice, although P29mtB6 cybrids form tumor masses under the
same host environment [16]. NZB mtDNA possesses a number
of non-pathogenic, polymorphic alterations of nucleotides
compared with B6 mtDNA, and P29mtNZB cybrids appeared to
be recognized and eliminated by the innate immune system
just like allogenic (non-self) graft in the host B6 mice [16].
We therefore examined whether suppression of tumor
formation by P29mtSAMP1 cybrids is due to the immune
responses of host B6 mice (Figure 2). To this end, we used B6-
background immune deficient mice including NKRed mice, which
have a reduced number of NK cells as the result of
intraperitoneal injection of anti-NK1.1 antibody, and B6
MyD88-/-/Trif-/- mice, which are deficient in the innate immune
system due to the functional impairment of Toll-like receptors
and some cytokine receptors such as IL-1R and IL-18R. The
P29mtSAMP1 cybrids were able to form tumors in both B6
NKRed mice (Figure 2A) and B6 MyD88-/-/Trif-/- mice (Figure 2B),
although they showed longer latent periods than those of
P29mtB6 cybrids to form measurable tumor volumes. Probably,
the incomplete deficiency of innate immune system in these
mice may be responsible for the partial suppression of tumor
formation. These results indicated that suppression of tumor
formation of P29mtSAMP1 cybrids is the result of host immune
responses, and that the innate immune cells including NK and
other immune cells that utilize Myd88 or Trif adaptor molecules
for their function, are involved in the suppression of tumor
formation of P29mtSAMP1 cybrids in the B6 mice.
We further evaluated the contribution of the acquired
immune system to tumor suppression of P29mtSAMP1 cybrids
using B6 Rag2-/- (T and B cell–deficient) mice, which have a
defective acquired immune system due to deficiency of the
recombination-activating gene. P29mtSAMP1 cybrids failed to
form tumors in B6 Rag2-/- mice (Figure 2C). These results
indicate that the acquired immune system of host B6 mice was
not involved in the suppression of tumor formation of
P29mtSAMP1 cybrids (Figure 1C).
Involvement of NK cells and DCs in tumor suppression
of P29mtSAMP1 cybrids
The tumor formation in NKRed mice suggested that the NK
cells of B6 mice are involved in the suppression of tumor
formation of P29mtSAMP1 cybrids (Figure 2A). To further
provide evidence for the contribution of NK cells in tumor
suppression of P29mtSAMP1 cybrids, we performed in vitro
cytotoxic assays by co-cultivation of 51Cr-incorporated cybrids
with activated NK cells prepared from the B6 Rag2-/- mice. The
results showed that activated NK cells were more cytotoxic to
P29mtSAMP1 cybrids than to P29mtB6 cybrids (Figure 3).
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Thus, activated NK cells could recognize and kill P29mtSAMP1
cybrids preferentially.
The experiments using B6 MyD88-/-/Trif-/- mice suggested
that in addition to NK cells, other innate immune cells, such as
DCs, are involved in the suppression of tumor formation of
P29mtSAMP1 cybrids (Figure 2B). Therefore, we examined the
contribution of DCs by using B6 CD11c-DTR mice, which lack
DCs after the administration of DTx owing to exclusive
expression of its receptor (DTR) in CD11c+ DCs. Depletion of
DCs by DTx allowed tumor formation of P29mtSAMP1 cybrids,
although they showed longer latent periods than those of
P29mtB6 cybrids (Figure 4).
To obtain insight into how DCs are involved in tumor
suppression of P29mtSAMP1 cybrids, we carried out in vitro
co-cultivation of DCs from B6 mice and P29mtSAMP1 cybrids.
We expected that B6-derived DCs somehow discriminate
P29mtSAMP1 cybrids from P29mtSAMP1, because DCs are
central to trigger the innate immune responses. We then
compared the amounts of cytokines produced by DCs, and
found that IL-6 secretion was exclusively increased after the
co-cultivation of DCs with P29mtSAMP1 cybrids (Figure 5).
This suggests that P29mtSAMP1 cybrids are more pro-
inflammatory in the host B6 environment than are P29mtB6
cybrids.
Mechanistic evaluation of immune surveillance against
P29mtSAMP1 cybrids
We next investigated how alterations of mtDNA in
P29mtSAMP1 cybrids elicited the innate immune response
dependent on NK cells and DCs. Comparison of registered
mtDNA sequences of B6 mice and SAMP1 mice [17] revealed
that only four mutations are present in SAMP1 mtDNA (Table
Figure 2.  Involvement of immune systems of B6 mice in the suppression of tumor formation of P29mtSAMP1
cybrids.  P29mtB6 and P29mtSAMP1 cybrids were inoculated under the skin of (A) B6 NKRed mice, which lack NK cells, (B) B6
Myd88-/-Trif-/- mice, which lack a functional innate immune system, and (C) B6 Rag2-/- mice lacking the acquired immune system (n =
3 per group). P29mtSAMP1 cybrids formed primary tumor masses in B6 mice only in the absence of functional innate immune
system, indicating that innate immune system is responsible for suppression of the tumor formation phenotype of P29mtSAMP1
cybrids.
doi: 10.1371/journal.pone.0075981.g002
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S2): a point mutation in the 16S rRNA gene, a silent mutation
in the ND3 (NADH dehydrogenase subunit 3) gene, a
missense mutation in the ND4 gene, and a silent mutation in
the ND5 gene. In addition, we newly identified one additional
missense mutation in the ND5 gene by determining the entire
mtDNA sequence of P29mtSAMP1 cybrids (Table 1).
In light of these observations, we sought to determine which
components in P29mtSAMP1 cybrids, i.e. the SAMP1 mtDNA
itself, its-related transcripts, or peptides/proteins, define IL-6-
Figure 3.  Involvement of NK cells in the specific killing of P29mtSAMP1 cybrids.  Cytotoxic assays of P29mtB6 and
P29mtSAMP1 cybrids (target cells) used B6 Rag2-/- splenocytes (effector cells) without T cells and B cells at indicated E/T ratios
(effector cells to target cells ratios). Specific killing of P29mtSAMP1 cybrids was observed. *P < 0.05, **P < 0.01.
doi: 10.1371/journal.pone.0075981.g003
Figure 4.  Involvement of DCs in the suppression of tumor formation of P29mtSAMP1 cybrids in B6 mice.  P29mtB6 and
P29mtSAMP1 cybrids were inoculated under the skin of B6 CD11c-DTR mice, which have lost DCs by the administration of DTx (n
= 3 per group). P29mtSAMP1 cybrids formed primary tumor masses in B6 CD11c-DTR mice, only when the mice were treated with
DTx, indicating that DCs are at least in part involved in suppression of the tumor formation phenotype of P29mtSAMP1 cybrids.
doi: 10.1371/journal.pone.0075981.g004
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inducible, pro-inflammatory nature of P29mtSAMP1 cybrids. To
this end, we pretreated P29mtSAMP1 cybrids either with
DNase, RNase, or trypsin, and then co-cultivated them with B6
DCs to test the effects of the pretreatment on the secretion of
IL-6 from DCs. Whereas DNase or RNase pretreatment had no
effect on the amount of IL-6 secreted from DCs, trypsin
pretreatment significantly inhibited IL-6 secretion (Figure 6).
These results suggest that peptides/proteins probably
expressed on cell surface of P29mtSAMP1 cybrids, but not any
nucleic acid components including mtDNA itself or transcripts
of SAMP1 mtDNA, possess a potential to modify DC functions
to regulate the innate immune response.
We further examined tumor formation of P29mtSAMP1
cybrids in B6 mice without nucleic acid-recognizable TLRs to
carefully make sure whether some nucleic acid components-
dependent elicitation of immune responses could be involved in
the tumor suppression phenotype of P29mtSAMP1 cybrids.
Although all TLRs are pattern recognition receptor, and none of
examined TLRs is able to distinguish mtDNA sequence with or
without mutations, it is also possible that changes of the
conformation or changes of the localization of mtDNA
fragments as the results of the mtDNA mutations may be
recognized by pattern recognition receptors. The B6 mice
deficient in TLR-3, 7, or 9, which recognizes double-stranded
RNA, single-stranded RNA, and double-stranded DNA,
respectively, still maintained an ability to suppress tumor
formation of P29mtSAMP1 cybrids (Figure 7). Thus, these
results exclude a possibility that nucleic acid components
including SAMP1 mtDNA directly elicit the innate immune
responses through TLRs.
Figure 5.  Identification of the cytokines secreted from DCs and increased in amount after co-culture with P29mtSAMP1
cybrids.  DCs from B6 mice were co-cultured with P29mtB6 or P29mtSAMP1 cybrids; the supernatant was harvested to measure
cytokine production. We assessed whether IL-6, TNF-α, MCP-1, IL-10, or IL-12p70 secreted from DCs possibly activated NK cells.
IL-6 secretion was increased exclusively after the co-culture of DCs with P29mtSAMP1 cybrids, whereas no significant differences
between P29mtSAMP1 and P29mtB6 cybrids were detectable in other cytokines produced by DCs, such as TNF-α, MCP-1, IL-10,
and IL-12p70. **P < 0.01.
doi: 10.1371/journal.pone.0075981.g005
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Discussion
Our previous study [8] showed that P29mtA11 cybrids with
mtDNA from highly metastatic Lewis lung carcinoma cells (A11
cells) expressed ROS overproduction, which induced tumor
progression (metastasis). In the current study, we transferred
mtDNA from SAMP1 mice into ρ0 P29 cells, isolated new
transmitochondrial P29mtSAMP1 cybrids that overproduce
ROS, and examined whether mtDNA mutations that induced
ROS overproduction always confer tumor progression. The
results unexpectedly showed that some of the mutations in
mtDNA from SAMP1 mice conversely suppressed tumor
phenotypes (Figure 1A) due to activation of innate immune
responses mediated by DCs and NK cells (Figures 1–3). This
finding suggests that some mtDNA mutations in mice function
as tumor suppressors (Figure 1), while the other mtDNA
mutations function as tumor enhancers [8], even though they
both induce ROS overproduction.
It may be possible that the mtDNA mutations in
P29mtSAMP1 cybrids cause ROS-mediated protein
denaturation, and the denatured proteins consequently
enhance antigenicity of P29mtSAMP1 cybrids. However, our
previous study [16] reported that P29mtNZB cybrids
possessing mtDNA from NZB mice did not show ROS
overproduction, but showed suppression of tumor formation in
host B6 mice through elicitation of the innate immune
responses in the absence of ROS overproduction. Moreover,
P29mtA11 cybrids showed significant ROS overproduction, but
showed enhanced tumor formation in host B6 mice [8]. These
observations suggest that ROS-mediated protein denaturation
would not be involved in activation of innate immune cells,
although we could not completely exclude this possibility.
Probably, alterations in structure or expression levels of
proteins and/or nucleic acids arose from mtDNA mutations in
some way trigger activation of the innate immune cells.
In the case of P29mtNZB cybrids [16], mtDNA from NZB
strain mice harbored more than 90 mutation sites (Table S2).
Therefore, it was difficult to determine which mutations are
responsible for the recognition by the innate immune system. In
contrast, the mtDNA of P29mtSAMP1 cybrids possessed only
five mutations compared with the mtDNA of B6 mice (Table 1).
Moreover, pretreatment of P29mtSAMP1 cybrids with RNase,
DNase, and protease, respectively (Figure 6) revealed that
some peptides that arose from P29mtSAMP1 cybrids, but not
mtDNA fragments or transcripts of mtDNA, are candidate
mitochondrial components recognized by the innate immune
cells. We confirmed that B6 mice deficient in pattern
recognition receptors of nucleic acids still maintained an ability
to suppress tumor formation of P29mtSAMP1 cybrids,
suggesting that changes of the conformation or changes of the
localization of mtDNA fragments as the results of the mtDNA
mutations are not involved in the innate immune recognition.
Enzyme pretreatment experiments of P29mtSAMP1 cybrids
revealed that some peptides expressed on P29mtSAMP1
cybrids induce increased IL-6 production by B6 DCs (Figure 6).
Although we do not exclude a possibility that other cytokines
and/or inflammatory mediators also induced in DCs upon co-
cultivation with P29mtSAMP1 cybrids, our results proposed an
interesting possibility that peptides might be expressed on the
surface of P29mtSAMP1 cybrids, and mediate augmented
inflammatory responses around the tumor-inoculated
environment. We currently speculate that mtDNA mutations
lead to alterations of structures of protein products translated
from the transcripts of mtDNA, and that such structural
instability or fragility of cellular components may cause stress
response to make cells to express stress/danger signals or
unusual trafficking of mutated mtDNA-derived components to
the cell surface.
Our current results prompt the question of whether any
cybrids with mtDNA from allogenic strains (strains other than
B6) are recognized by the immune system of host B6 strain
Figure 6.  Identification of mitochondrial components that are recognized by DCs.  We assessed the effect of pretreating
P29mtSAMP1 cybrids with DNase, RNase, or trypsin on the secretion of IL-6 from DCs because not only mtDNA-encoded peptides
but also mtDNA itself and the mitochondrial RNAs transcribed from mtDNA could be mitochondrial components that are specifically
recognized by DCs and that result in enhanced secretion of IL-6. *P < 0.05.
doi: 10.1371/journal.pone.0075981.g006
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mice. Our previous study [16] showed that P29mtC3H cybrids
with nuclear DNA from B6-derived P29 cells and mtDNA from
C3H strain mice were able to form tumors in B6 mice.
Comparison of the full-length sequences of mtDNA from B6
mice and P29mtC3H showed that mtDNA from P29mtC3H
Figure 7.  Effects of the absence of Toll-like receptors in
B6 mice on tumor formation of P29mtSAMP1 cybrids.  To
confirm the idea that mtDNA and its transcripts are not the
mitochondrial components in P29mtSAMP1 cybrids that are
recognized by innate immune cells in B6 mice, we assessed
tumor formation of P29mtSAMP1 cybrids in B6 mice that
lacked (A) TLR-3 (B) TLR-7, or (C) TLR-9, which recognized
double-stranded RNA, single-stranded RNA, and double-
stranded DNA, respectively.
doi: 10.1371/journal.pone.0075981.g007
cybrids carries only three missense mutations, all of which are
different from those in the mtDNA from P29mtSAMP1 (Table
1). This result suggests that missense mutations in mtDNA
from different strains are not always recognized by the immune
systems of B6 strain mice.
Induced-pluripotent stem (iPS) cells that have the same
nuclear DNA background as their nuclear donors are
considered to be promising cellular systems for regenerating
tissues that will not be rejected after differentiation and
transplantation into a host [18–20]. However, our observations
suggest that some somatic mutations of mtDNA in tissues
could be targets of innate immune cells. Therefore, as the
mtDNA in somatic cells accumulates somatic mutations during
the aging of the donor, the regenerated tissues from iPS cells
with particular somatic mutations in mtDNA could be targets of
host innate immune cells, resulting in the rejection of the
transplanted tissues.
Many questions remain regarding the mechanism by which
innate immune cells, such as DCs and NK cells, selectively
recognize and exclude P29mtSAMP1 cybrids. It is also
unknown how the ND4 and ND5 peptides, which are translated
from the ND4 and ND5 genes and which usually integrate into
the mitochondrial inner membranes, localize on the cell surface
of P29mtSAMP1 cybrids to function as mitochondrial
components to be recognized by innate immune cells. In
addition, it is unclear which molecules in the innate immune
cells recognize the mitochondrial components. Moreover, we
could not complete exclude the possibility that ROS
overproduction is involved in the specific killing of
P29mtSAMP1 cybrids by the innate immune system. Although
the precise mechanism needs to be further investigated, our
current study provides information that potentially is important
for the fields of mitochondrial tumor immunology and
regenerative medicine using iPS cells.
Supporting Information
Table S1.  Genetic characteristics of parent cells and
P29mtSAMP1 cybrids. a) Fusion mixture was grown in a
selection medium without uridine and pyruvate (UP-) that
allows exclusive growth of the mtDNA-repopulated ρ0P29 cells
corresponding to P29mtSAMP1 cybrids. Platelets without
nuclei cannot survive, and unfused ρ0P29 cells failed to grow in
the selection medium due to significant respiration defects
caused by the absence of mtDNA.
(XLS)
Table S2.  Comparison of sequences of mtDNA from
different mouse strains. The GenBank accession numbers
for the mtDNA sequences of B6, SAMP1, C3H, and NZB are
AY172335, AB042524, AB049357, and L07095, respectively.
n.p.: nucleic position. a.a. change: amino acid change.
(XLS)
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